Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance.

Nagai Y, Yonemitsu S, Erion DM, Iwasaki T, Stark R, Weismann D, Dong J, Zhang D, Jurczak MJ, Löffler MG, Cresswell J, Yu XX, Murray SF, Bhanot S, Monia BP, Bogan JS, Samuel V, Shulman GI.

Cell Metab. 2009 Mar;9(3):252-64. doi: 10.1016/j.cmet.2009.01.011.

2.

Transcriptional co-activator peroxisome proliferator-activated receptor (PPAR)gamma co-activator-1beta is involved in the regulation of glucose-stimulated insulin secretion in INS-1E cells.

Oberkofler H, Hafner M, Felder T, Krempler F, Patsch W.

J Mol Med (Berl). 2009 Mar;87(3):299-306. doi: 10.1007/s00109-008-0425-0.

PMID:
19082571
4.
6.

Silymarin ameliorates fructose induced insulin resistance syndrome by reducing de novo hepatic lipogenesis in the rat.

Prakash P, Singh V, Jain M, Rana M, Khanna V, Barthwal MK, Dikshit M.

Eur J Pharmacol. 2014 Mar 15;727:15-28. doi: 10.1016/j.ejphar.2014.01.038.

PMID:
24486395
7.

The role of proliferator-activated receptor gamma coactivator-1alpha in the fatty-acid-dependent transcriptional control of interleukin-10 in hepatic cells of rodents.

Morari J, Torsoni AS, Anhê GF, Roman EA, Cintra DE, Ward LS, Bordin S, Velloso LA.

Metabolism. 2010 Feb;59(2):215-23. doi: 10.1016/j.metabol.2009.07.020.

PMID:
19766270
8.

Amelioration of lipid-induced insulin resistance in rat skeletal muscle by overexpression of Pgc-1β involves reductions in long-chain acyl-CoA levels and oxidative stress.

Wright LE, Brandon AE, Hoy AJ, Forsberg GB, Lelliott CJ, Reznick J, Löfgren L, Oscarsson J, Strömstedt M, Cooney GJ, Turner N.

Diabetologia. 2011 Jun;54(6):1417-26. doi: 10.1007/s00125-011-2068-x.

PMID:
21331471
9.

Fructose induces gluconeogenesis and lipogenesis through a SIRT1-dependent mechanism.

Caton PW, Nayuni NK, Khan NQ, Wood EG, Corder R.

J Endocrinol. 2011 Mar;208(3):273-83. doi: 10.1530/JOE-10-0190.

10.

PGC-1β modulates the expression of genes involved in mitochondrial function and adipogenesis during preadipocyte differentiation.

Ji H, Lu RH, Chang ZG, Su SS, Yang GS.

Reprod Domest Anim. 2012 Jun;47(3):419-27. doi: 10.1111/j.1439-0531.2011.01894.x.

PMID:
22008020
11.

PGC-1β suppresses saturated fatty acid-induced macrophage inflammation by inhibiting TAK1 activation.

Chen H, Liu Y, Li D, Song J, Xia M.

IUBMB Life. 2016 Feb;68(2):145-55. doi: 10.1002/iub.1470.

PMID:
26748475
12.

Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha.

Nagai Y, Nishio Y, Nakamura T, Maegawa H, Kikkawa R, Kashiwagi A.

Am J Physiol Endocrinol Metab. 2002 May;282(5):E1180-90.

13.

Selenoprotein P expression is controlled through interaction of the coactivator PGC-1alpha with FoxO1a and hepatocyte nuclear factor 4alpha transcription factors.

Speckmann B, Walter PL, Alili L, Reinehr R, Sies H, Klotz LO, Steinbrenner H.

Hepatology. 2008 Dec;48(6):1998-2006. doi: 10.1002/hep.22526.

PMID:
18972406
14.

SIRT1 interacts with metabolic transcriptional factors in the pancreas of insulin-resistant and calorie-restricted rats.

Chen YR, Lai YL, Lin SD, Li XT, Fu YC, Xu WC.

Mol Biol Rep. 2013 Apr;40(4):3373-80. doi: 10.1007/s11033-012-2412-3.

PMID:
23292098
15.

Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression.

Estall JL, Kahn M, Cooper MP, Fisher FM, Wu MK, Laznik D, Qu L, Cohen DE, Shulman GI, Spiegelman BM.

Diabetes. 2009 Jul;58(7):1499-508. doi: 10.2337/db08-1571.

16.

Hepatic PGC-1beta overexpression induces combined hyperlipidemia and modulates the response to PPARalpha activation.

Lelliott CJ, Ljungberg A, Ahnmark A, William-Olsson L, Ekroos K, Elmgren A, Arnerup G, Shoulders CC, Oscarsson J, Lindén D.

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2707-13.

17.

Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis.

Bhatnagar S, Damron HA, Hillgartner FB.

J Biol Chem. 2009 Apr 10;284(15):10023-33. doi: 10.1074/jbc.M808818200.

18.

p38 mitogen-activated protein kinase plays an inhibitory role in hepatic lipogenesis.

Xiong Y, Collins QF, An J, Lupo E Jr, Liu HY, Liu D, Robidoux J, Liu Z, Cao W.

J Biol Chem. 2007 Feb 16;282(7):4975-82.

19.

Whole body overexpression of PGC-1alpha has opposite effects on hepatic and muscle insulin sensitivity.

Liang H, Balas B, Tantiwong P, Dube J, Goodpaster BH, O'Doherty RM, DeFronzo RA, Richardson A, Musi N, Ward WF.

Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E945-54. doi: 10.1152/ajpendo.90292.2008.

Items per page

Supplemental Content

Support Center